The Advantages of Lyophilizing Assay Reagents
With an ever increasing need to reduce our carbon footprint, we need to find alternative solutions to our shared challenges, and biotechnology- for all it’s
With an ever increasing need to reduce our carbon footprint, we need to find alternative solutions to our shared challenges, and biotechnology- for all it’s
Why Your Biotech Contract Manufacturer is Expanding in Combination Product and Drug-Fill/Finish in 2024 Letter to Our Colleagues, from Founder/CEO Wayne Woodard, Argonaut Manufacturing Services
The biotech diagnostic manufacturing and development industry is undergoing rapid transformation driven by innovations that enhance sustainability and improve access to accurate diagnoses while optimizing
In recent years, the field of biotechnology has experienced significant progress, particularly in diagnostic manufacturing. Biotech diagnostic manufacturing ecosystems have evolved into dynamic networks comprising
As we wrap up 2023 and look ahead to 2024, the biotech industry reflects on a challenging year behind us marked by the aftermath of
… but things may be looking up. Marketplace Podcast, Interview With CEO Wayne Woodard Public media podcast, Marketplace, delves into the intricate responses of manufacturing
Argonaut Manufacturing Services in a Molecule to Market Podcast Episode In the podcast series Molecule to Market, Raman Sehgal interviews influential leaders in the biopharmaceutical
What can we learn from last year’s biotech/pharma manufacturing As the JPM meeting of 2023 closes, what can we learn from the last year and
Updated October 16, 2022 In 2008-2010, the economic downturn in biotech wreaked havoc on the unprepared industry. Fast forward to late 2022, and the economic
Opinion: Wayne Woodard, CEO Argonaut Manufacturing Services Molecular Diagnostic Manufacturing in USA In early September 2020, I wrote an opinion piece titled “Bring Manufacturing Back